Loading company…
Telormedix develops targeted cancer therapies and diagnostics.
Telormedix develops targeted therapeutics and diagnostics for cancer, serving healthcare providers and researchers in oncology. Founded in 2007, it is based in Switzerland. The company has completed 8 deals and raised CHF 6.000 mn in a Series B round from Aravis and ProQuest Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in